We seek to engage in ongoing dialogue with a broad range of industry and corporate experts to develop unique and differentiated sources of information. We look to identify investment alternatives that may be mispriced or misunderstood by the broader investing community.
Our strategies also specialize in creating detailed alternative scenario analysis that can highlight potential investment opportunities. Our evolving focus is on presenting those investment cases to institutional investors in a clear and concise fashion.
OUR ANALYSTS
Jules Augus Supervisory Analyst – Equity Research |
View Bio and Coverage» |
Nathan Weinstein Managing Director Head of Healthcare Equity Research |
View Bio and Coverage» |
Rommel Dionisio Head of Consumer Products and Special Situations | Managing Director, Supervisory Analyst |
View Bio and Coverage» |
Brian Hollenden Managing Director Financial Institutions and Cannabis Equity Research |
View Bio and Coverage» |